Skip to main content
. 2023 Jan 18;108(3):213–223. doi: 10.1159/000528252

Table 3.

Demographics of ICU patients treated with RRT versus without RRT

Overall, (N = 45) RRT(−), (N = 9) RRT(+), (N = 36) p value
Outcome, n (%)
 Survivor 37 (82) 6 (67) 31 (86) 0.3
 Non-survivor 8 (18) 3 (33) 5 (14)
Age, years 67 (55, 74) 55 (32, 60) 70 (58, 75) 0.015
Gender, n (%) 0.7
 Female 29 (64) 5 (56) 24 (67)
 Male 16 (36) 4 (44) 12 (33)
Metformin doses, mg/days 2,550 (1,775, 3,000) 15,000 (14,500, 15,000) 2,550 (1,700, 3,000) 0.037
 Unknown 11 6 5
Metformin concentration, µg/mL (plasma/serum) 60 (42, 80) NA (NA, NA) 60 (42, 80) NA
 Unknown 32 9 23
Creatinine (median), µmol/L (plasma/serum) 511 (246, 779) 126 (93, 250) 647 (371, 799) <0.001
Arterial pH 6.90 (6.80, 7.09) 7.25 (7.09, 7.28) 6.88 (6.73, 7.01) <0.001
Lactate (median), mmol/L 15 (12, 19) 9 (6, 16) 15 (13, 19) 0.057
Bicarbonate, mmol/L 5.2 (2.5, 11.0) 14.0 (11.5, 14.8) 4.3 (2.4, 7.0) 0.006
 Unknown 13 3 10
Acute renal impairment, n (%)
 No 10 (29) 7 (78) 3 (12) <0.001
 Yes 25 (71) 2 (22) 23 (88)
 Unknown 10 0 10
Diarrhea/vomiting days before admission, n (%)
 No 9 (41) 0 (NA) 9 (41) >0.9
 Yes 13 (59) 0 (NA) 13 (59)
 Unknown 23 9 14
Chronic renal impairment, n (%)
 No 18 (64) 6 (100) 12 (55) 0.062
 Yes 10 (36) 0 (0) 10 (45)
 Unknown 17 3 14
Liver impairment/alcoholism, n (%)
 No 14 (78) 4 (67) 10 (83) 0.6
 Yes 4 (22) 2 (33) 2 (17)
 Unknown 27 3 24
Infection, n (%)
 No 10 (59) 2 (33) 8 (73) 0.2
 Yes 7 (41) 4 (67) 3 (27)
 Unknown 28 3 25
Other reasons for hypoxia, n (%)
 No 12 (46) 2 (33) 10 (50) 0.7
 Yes 14 (54) 4 (67) 10 (50)
 Unknown 19 3 16